This work is licensed under the Creative Commons Attribution 4.0 International License.
Nikfarjam J, Chambers E. Congenital melanocytic nevi and the risk of malignant melanoma: establishing a guideline for primary-care physicians. Einstein J Biol Med. 2011;27(2):59-66. doi: 10.23861/EJBM20112745.NikfarjamJChambersECongenital melanocytic nevi and the risk of malignant melanoma: establishing a guideline for primary-care physiciansEinstein J Biol Med2011272596610.23861/EJBM20112745Open DOISearch in Google Scholar
Shah J, Feintisch AM, Granick MS. Congenital melanocytic nevi. Eplasty. 2016 Jan 28;16:ic4.ShahJFeintischAMGranickMSCongenital melanocytic neviEplasty2016281610.1097/MOP.000000000000038427307047Search in Google Scholar
del Carmen Boente M. Congenital melanocytic nevi. p. 249-60. In: Pediatric skin of color. Eds. Silverberg NB, Durán-McKinster C, Tay Y-K. New York: Springer-Verlag, 2015; XV, 473 p. ISBN 9781-4614-6653-6 (hardcover). ISBN 978-1-4614-6654-3 (eBook). doi: 10.1007/978-1-4614-6654-3.Carmen Boente MdelCongenital melanocytic nevi. p. 249-60Pediatric skin of color. Eds. Silverberg NB, Durán-McKinster C, Tay Y-KNew YorkSpringer-Verlag2015XV, 473 p. ISBN 9781-4614-6653-6 (hardcover). ISBN 978-1-4614-6654-3 (eBook)10.1007/978-1-4614-6654-3Open DOISearch in Google Scholar
Price HN. Congenital melanocytic nevi: update in genetics and management. Curr Opin Pediatr. 2016;28(4):476-82. doi: 10.1097/MOP.0000000000000384.PriceHNCongenital melanocytic nevi: update in genetics and managementCurr Opin Pediatr20162844768210.1097/MOP.0000000000000384Open DOISearch in Google Scholar
Kinsler VA, Thomas AC, Ishida M, Bulstrode NW, Loughlin S, Hing S, et al. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol. 2013;133(9):2229-36. doi: 10.1038/jid.2013.70.KinslerVAThomasACIshidaMBulstrodeNWLoughlinSHingSet alMultiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRASJ Invest Dermatol2013133922293610.1038/jid.2013.70367897723392294Open DOISearch in Google Scholar
Krengel S, Scope A, Dusza SW, Vonthein R, Marghoob AA. New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. J Am Acad Dermatol. 2013;68(3):441-51. doi: 10.1016/j.jaad.2012.05.043.KrengelSScopeADuszaSWVontheinRMarghoobAANew recommendations for the categorization of cutaneous features of congenital melanocytic neviJ Am Acad Dermatol20136834415110.1016/j.jaad.2012.05.04322982004Open DOISearch in Google Scholar
Polubothu S, McGuire N, Al-Olabi L, Baird W, Bulstrode N, Chalker J, et al. Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi. Br J Dermatol. 2020;182(2):434-43. doi: 10.1111/bjd.18106.PolubothuSMcGuireNAl-OlabiLBairdWBulstrodeNChalkerJet alDoes the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naeviBr J Dermatol202018224344310.1111/bjd.18106702814031111470Open DOISearch in Google Scholar
Dessars B, De Raeve LE, Morandini R, Lefort A, El Housni H, Ghanem GE, et al. Genotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesis. J Invest Dermatol. 2009;129(1):139-47. doi: 10.1038/jid.2008.203.DessarsBDe RaeveLEMorandiniRLefortAElHousni HGhanemGEet alGenotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesisJ Invest Dermatol200912911394710.1038/jid.2008.20318633438Open DOISearch in Google Scholar
Bekiesińska-Figatowska M, Szczygielski O, Boczar M, Mądzik J, Klepacka T, Michalak E, et al. Neurocutaneous melanosis in children with giant congenital melanocytic nevi. Clin Imaging. 2014;38(2):79-84. doi: 10.1016/j.clinimag.2013.10.001.Bekiesińska-FigatowskaMSzczygielskiOBoczarMMądzikJKlepackaTMichalakEet alNeurocutaneous melanosis in children with giant congenital melanocytic neviClin Imaging2014382798410.1016/j.clinimag.2013.10.00124239041Open DOISearch in Google Scholar
Sawicka E, Szczygielski O, Żak K, Pęczkowski P, Michalak E, Bekiesińska-Figatowska M. Giant congenital melanocytic nevi: selected aspects of diagnostics and treatment. Med Sci Monit. 2015 Jan 11;21:123-32. doi: 10.12659/MSM.891279.SawickaESzczygielskiOKŻakPPęczkowskiEMichalakMBekiesińska-FigatowskaGiant congenital melanocytic nevi: selected aspects of diagnostics and treatmentMed Sci Monit2015Jan 11211233210.12659/MSM.891279429899825577155Open DOISearch in Google Scholar
Roh MR, Eliades P, Gupta S, Tsao H. Genetics of melanocytic nevi. Pigment Cell Melanoma Res. 2015;28(6):661-72. doi: 10.1111/pcmr.12412.RohMREliadesPGuptaSTsaoHGenetics of melanocytic neviPigment Cell Melanoma Res20152866617210.1111/pcmr.12412460961326300491Open DOISearch in Google Scholar
Ichii-Nakato N, Takata M, Takayanagi S, Takashima S, Lin J, Murata H, et al. High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi. J Invest Dermatol. 2006;126(9):2111-8. doi: 10.1038/sj.jid.5700366.Ichii-NakatoNTakataMTakayanagiSTakashimaSLinJMurataHet alHigh frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital neviJ Invest Dermatol200612692111810.1038/sj.jid.570036616691193Open DOISearch in Google Scholar
Charbel C, Fontaine RH, Malouf GG, Picard A, Kadlub N, El-Murr N, et al. NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi. J Invest Dermatol. 2014;134(4):1067-74. doi: 10.1038/jid.2013.429.CharbelCFontaineRHMaloufGGPicardAKadlubNEl-MurrNet alNRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic neviJ Invest Dermatol2014134410677410.1038/jid.2013.42924129063Open DOISearch in Google Scholar
Stark MS. Large-giant congenital melanocytic nevi: moving beyond NRAS mutations. J Invest Dermatol. 2019;139(4):756-9. doi: 10.1016/j.jid.2018.10.003.StarkMSLarge-giant congenital melanocytic nevi: moving beyond NRAS mutationsJ Invest Dermatol20191394756910.1016/j.jid.2018.10.00330904080Open DOISearch in Google Scholar
Alqathama A. BRAF in malignant melanoma progression and metastasis: potentials and challenges. Am J Cancer Res. 2020;10(4):1103-14.AlqathamaABRAF in malignant melanoma progression and metastasis: potentials and challengesAm J Cancer Res2020104110314Search in Google Scholar
Frech M, Darden TA, Pedersen LG, Foley CK, Charifson PS, Anderson MW, Wittinghofer A. Role of glutamine-61 in the hydrolysis of GTP by p21H-ras: an experimental and theoretical study. Biochemistry. 1994;33(11):3237-44. doi: 10.1021/bi00177a014.FrechMDardenTAPedersenLGFoleyCKCharifsonPSAndersonMWWittinghoferARole of glutamine-61 in the hydrolysis of GTP by p21H-ras: an experimental and theoretical studyBiochemistry1994331132374410.1021/bi00177a0148136358Open DOISearch in Google Scholar
Hélias-Rodzewicz Z, Funck-Brentano E, Terrones N, Beauchet A, Zimmermann U, Marin C, et al. Variation of mutant allele frequency in NRAS Q61 mutated melanomas. BMC Dermatol. 2017;17(1):9. doi: 10.1186/s12895-017-0061-x.Hélias-RodzewiczZFunck-BrentanoETerronesNBeauchetAZimmermannUMarinCet alVariation of mutant allele frequency in NRAS Q61 mutated melanomasBMC Dermatol2017171910.1186/s12895-017-0061-x549412828668077Open DOISearch in Google Scholar
Bauer J, Curtin JA, Pinkel D, Bastian BC. Congenital melanocytic nevi frequently harbour NRAS mutations but no BRAF mutations. J Invest Dermatol. 2007;127(1):179-82. doi: 10.1038/sj.jid.5700490.BauerJCurtinJAPinkelDBastianBCCongenital melanocytic nevi frequently harbour NRAS mutations but no BRAF mutationsJ Invest Dermatol200712711798210.1038/sj.jid.570049016888631Open DOISearch in Google Scholar
Martins da Silva V, Martinez-Barrios E, Tell-Martí G, Dabad M, Carrera C, Aguilera P, et al. Genetic abnormalities in large to giant congenital nevi: beyond NRAS mutations. J Invest Dermatol. 2019;139(4):900-8. doi: 10.1016/j.jid. 2018.07.045.Martinsda Silva VMartinez-BarriosETell-MartíGDabadMCarreraCAguileraPet alGenetic abnormalities in large to giant congenital nevi: beyond NRAS mutationsJ Invest Dermatol20191394900810.1016/j.jid.2018.07.04530359577Open DOISearch in Google Scholar
Pedersen M, Küsters-Vandevelde HVN, Viros A, Groenen PJTA, Sanchez-Laorden B, Gilhuis JH, et al. Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytes. Cancer Discov. 2013 ;3(4) :458-69. doi : 10.1158/2159-8290.CD-12-0464.PedersenMKüsters-VandeveldeHVNVirosAGroenenPJTASanchez-LaordenBGilhuisJHet alPrimary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytesCancer Discov2013344586910.1158/2159-8290.CD-12-0464399938223303902Open DOISearch in Google Scholar
Burd CE, Liu W, Huynh MV, Waqas MA, Gillahan JE, Clark KS, et al. Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma. Cancer Discov. 2014;4(12):1418-29. doi: 10.1158/2159-8290.CD-14-0729.BurdCELiuWHuynhMVWaqasMAGillahanJEClarkKSet alMutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanomaCancer Discov201441214182910.1158/2159-8290.CD-14-0729425818525252692Open DOISearch in Google Scholar
AACR Project GENIE Consortium. AACR Project GENIE: Powering Precision Medicine through an International Consortium. Cancer Discov. 2017;7(8):818-31. doi: 10.1158/2159-8290.CD-17-0151.AACR Project GENIE ConsortiumAACR Project GENIE: Powering Precision Medicine through an International ConsortiumCancer Discov2017788183110.1158/2159-8290.CD-17-0151561179028572459Open DOISearch in Google Scholar